Search
Perrigo Company PLC
PRGOAdd to Watchlist
9.950USD
+0.255+2.63%
Close 06/26, 16:00（ET）Quotes delayed by 15 min
1.38BMarket Cap
LossP/E TTM
Earnings Forecast
Currency: USD Updated: 2026-06-26The current earnings forecast score of Perrigo Company PLC is 6.50, ranking 129 out of 157 in the Pharmaceuticals industry. The average price target is 20.00, with a high of 20.00 and a low of 18.00.
Analyst Rating
Based on
4
analysts
Hold
Current Rating
15.500
Target Price
+60.12%
Upside Space
Strong Buy
Buy
Hold
Sell
Strong Sell
Peer Comparison
177
Total
6
Median
8
Average
Company name
Ratings
Analysts
Perrigo Company PLC
PRGO
4
Amgen Inc
AMGN
38
Biogen Inc
BIIB
38
Eli Lilly and Co
LLY
35
AbbVie Inc
ABBV
34
Vertex Pharmaceuticals Inc
VRTX
34
1
2
3
...
36
Support & Resistance
Relevant data have not been disclosed by the company yet.
Financial Forecasting
EPS
Revenue
Net Profit
EBIT
Forecast
Actual
Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.
FAQs
What is Perrigo Company PLC's expected revenue for the next quarter?
Perrigo Company PLC's expected revenue is 1.01B.
What is Perrigo Company PLC's price target?
Analysts forecast that Perrigo Company PLC's price target is USD 20.00, with the highest forecast at USD 20.00 and the lowest forecast at USD 18.00.
How have Perrigo Company PLCPRGO's recent earnings per share performed?
The market expectation was USD -2.87, while Perrigo Company PLCPRGO's earnings per share (EPS) for the previous quarter was USD -10.31. EPS for the next quarter is expected at USD 0.34.
What is the analyst rating for Perrigo Company PLC?
Based on the ratings of Perrigo Company PLC's stock from 4 analysts, most analysts support a signal_hold trend. After considering the opinions of other analysts, we ultimately rate Apple's stock as signal_hold. Please note that this is not trading advice. You still need to conduct your own analysis.
